Article ID Journal Published Year Pages File Type
8247083 International Journal of Radiation Oncology*Biology*Physics 2006 7 Pages PDF
Abstract
Conclusions: The 10-year DSS rate supports the efficacy of brachytherapy. Patients dying with disease within 10 years after treatment harbor inherently aggressive cancer with high Gleason scores and short DT.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Disease-specific survival following the brachytherapy management of prostate cancer
Authors
, , ,